A number of other equities research analysts also recently commented on SRCL. Imperial Capital reduced their target price on Stericycle from $100.00 to $95.00 and set an in-line rating for the company in a report on Thursday, May 26th. Royal Bank Of Canada reissued a sell rating on shares of Stericycle in a report on Thursday, May 26th. Zacks Investment Research downgraded Stericycle from a buy rating to a hold rating in a report on Monday, July 25th. Jefferies Group reissued a buy rating and issued a $140.00 target price on shares of Stericycle in a report on Monday, July 18th. Finally, Wellington Shields downgraded Stericycle from an accumulate rating to a hold rating in a report on Friday, July 29th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of $104.95.
Shares of Stericycle (NASDAQ:SRCL) traded up 0.158% during midday trading on Thursday, hitting $79.385. 149,662 shares of the company were exchanged. The stock has a market capitalization of $6.75 billion, a price-to-earnings ratio of 27.943 and a beta of 0.27. The company has a 50-day moving average price of $84.23 and a 200-day moving average price of $102.26. Stericycle has a 52-week low of $76.76 and a 52-week high of $151.57.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.18. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The firm had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. During the same period last year, the firm posted $1.14 EPS. Stericycle’s quarterly revenue was up 24.6% on a year-over-year basis. On average, analysts forecast that Stericycle will post $4.67 EPS for the current year.
In other Stericycle news, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the sale, the executive vice president now owns 1,088 shares in the company, valued at approximately $89,052.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Mark C. Miller sold 34,835 shares of Stericycle stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $104.52, for a total value of $3,640,954.20. Following the completion of the sale, the director now owns 244,284 shares of the company’s stock, valued at approximately $25,532,563.68. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the stock. Balentine LLC boosted its stake in Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock valued at $127,000 after buying an additional 160 shares during the period. Pinkerton Retirement Specialists LLC acquired a new stake in Stericycle during the second quarter valued at approximately $131,000. Parkside Financial Bank & Trust boosted its stake in Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock valued at $149,000 after buying an additional 41 shares during the period. Meeder Asset Management Inc. acquired a new stake in Stericycle during the second quarter valued at approximately $155,000. Finally, Canada Pension Plan Investment Board boosted its stake in Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock valued at $179,000 after buying an additional 497 shares during the period. Institutional investors own 92.80% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.